First Hospital of Jilin University
Changchun, Jilin, 130000, China
NCT Number: NCT02425696
The purpose of the study is to evaluate the prevalence and extent of right-to-left shunt (RLS) in Chinese migraineurs, and the morbidity of silent cerebral infarction in migraineurs.
Looking for future studies?
Notify Me16 year–65 year
All sexes
Observational
Changchun, Jilin, 130000, China
This is a prospective multicenter study of Chinese population. Participants (normal individuals without migraine and migraineurs) are included after standardized diagnostic procedures (TCD and c-TCD). For migraineurs with large RLS further examinations (c-TTE and brain MRI) are required. Up to 10 study sites nationwide will be needed to recruit the planned participant population during a 1-year period.
The information of each participants will be registered, including basic facts, the longitudinal headache history, frequency, location, quality, intensity, duration, accompanied symptoms, precipitating and exacerbating factors, with or without aura, MIDAS and HIT-6 questionnaire.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Time frame: 1 year
Yingqi Xing
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06938347
Right-To-Left Shunt
Chicago, Illinois, United States
View Trial DetailsNCT07519876
Atrial Septal Defects, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT00200356
Brain Diseases, Brain Infarction
View Trial DetailsNCT04530110
Brain Diseases, Central Nervous System Diseases
Aurora, Colorado, United States
View Trial Details